Top news of the day from across the health care landscape.
 

The differences in subcutaneous formulation preparation and the corresponding impact on practice.

A researcher at the Washington University School of Medicine in St.Louis has received close to $7.5 million in total funding for research towards development of stem cell-based treatments for chronic pulmonary disease (COPD), asthma, and other disorders.

A study by the CDC has found that only approximately half of pregnant women reported receiving the influenza, and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccines.

This video is sponsored by VaxServe, a Sanofi Pasteur company.

Although 62% of the first professional degrees in pharmacy were awarded to women in 2017-2018,¹ there are only about half as many female pharmacy owners as there are women graduating from pharmacy school.

“Sesame Street” has joined the fight against opioid addiction by creating a new character, Karli, a yellow-haired Muppet, to help educate children about the opioid epidemic and how it affects families.

Lasmiditan (Reyvow, Eli Lilly) resolved pain and most bothersome symptoms within 2 hours of treatment in patients with migraine.
 

Top news of the week from Specialty Pharmacy Times. 

This article is the third in a series on difficult to pronounce drug names.

Experts consider the reasoning behind flat dosing of subcutaneous formulations, as well as its added benefit.

Officials from the FDA have allowed marketing of a rapid diagnostic test (RDT) to help detect Ebola virus antigens in the bloodstream from certain living individuals and samples from recently deceased individuals suspected to have Ebola.